400 related articles for article (PubMed ID: 30220319)
1. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
Keck MK; Zuo Z; Khattri A; Stricker TP; Brown CD; Imanguli M; Rieke D; Endhardt K; Fang P; Brägelmann J; DeBoer R; El-Dinali M; Aktolga S; Lei Z; Tan P; Rozen SG; Salgia R; Weichselbaum RR; Lingen MW; Story MD; Ang KK; Cohen EE; White KP; Vokes EE; Seiwert TY
Clin Cancer Res; 2015 Feb; 21(4):870-81. PubMed ID: 25492084
[TBL] [Abstract][Full Text] [Related]
4. The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
Tian S; Wang C; Zhang J; Yu D
BMC Med Genomics; 2020 Feb; 13(1):18. PubMed ID: 32024523
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
6. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
8. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma.
Pavón MA; Parreño M; Téllez-Gabriel M; Sancho FJ; López M; Céspedes MV; Casanova I; Lopez-Pousa A; Mangues MA; Quer M; Barnadas A; León X; Mangues R
Carcinogenesis; 2012 Sep; 33(9):1707-16. PubMed ID: 22696598
[TBL] [Abstract][Full Text] [Related]
10. Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.
De Cecco L; Nicolau M; Giannoccaro M; Daidone MG; Bossi P; Locati L; Licitra L; Canevari S
Oncotarget; 2015 Apr; 6(11):9627-42. PubMed ID: 25821127
[TBL] [Abstract][Full Text] [Related]
11. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
12. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
[TBL] [Abstract][Full Text] [Related]
13. Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach.
Reddy RB; Khora SS; Suresh A
PLoS One; 2019; 14(7):e0218989. PubMed ID: 31310629
[TBL] [Abstract][Full Text] [Related]
14. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
15. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
16. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.
Wood O; Woo J; Seumois G; Savelyeva N; McCann KJ; Singh D; Jones T; Peel L; Breen MS; Ward M; Garrido Martin E; Sanchez-Elsner T; Thomas G; Vijayanand P; Woelk CH; King E; Ottensmeier C;
Oncotarget; 2016 Aug; 7(35):56781-56797. PubMed ID: 27462861
[TBL] [Abstract][Full Text] [Related]
17. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
[TBL] [Abstract][Full Text] [Related]
18. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
19. Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.
Ren H; Li H; Li P; Xu Y; Liu G; Sun L
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32500914
[TBL] [Abstract][Full Text] [Related]
20. Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma.
Zou J; Chu S; Bao Q; Zhang Y
Medicine (Baltimore); 2023 Aug; 102(31):e34586. PubMed ID: 37543795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
